1. Home
  2. TOWN vs EWTX Comparison

TOWN vs EWTX Comparison

Compare TOWN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$37.22

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$42.03

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
EWTX
Founded
1998
2017
Country
United States
United States
Employees
1939
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TOWN
EWTX
Price
$37.22
$42.03
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$39.00
AVG Volume (30 Days)
480.4K
1.1M
Earning Date
04-22-2026
05-07-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.63
N/A
Revenue Next Year
$5.18
N/A
P/E Ratio
$16.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.91
$13.69
52 Week High
$39.03
$48.40

Technical Indicators

Market Signals
Indicator
TOWN
EWTX
Relative Strength Index (RSI) 52.52 47.95
Support Level $36.98 $41.98
Resistance Level $38.01 $45.48
Average True Range (ATR) 0.50 2.06
MACD -0.10 -0.42
Stochastic Oscillator 65.39 28.07

Price Performance

Historical Comparison
TOWN
EWTX

About TOWN TowneBank

Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: